Paper 07 - ARTEMIS-002: A PHASE 2 STUDY OF HS-20093 IN PATIENTS WITH RELAPSED OR REFRACTORY SARCOMAS

Author(s)

• 

  Lu Xie

  Deputy Medical Director
  Musculoskeletal Tumor Centre, Peking University People's Hospital
  Beijing, Beijing, China (People's Republic)

  Slides

Co-Author(s)

• 

  Jingnan Shen, PhD

  leader
  Musculoskeletal Oncology, 1st Affiliated Hospital of Sun Yat-sen University
  Guangzhou, Guangdong, China (People's Republic)
• 

  Jie Xu, n/a

  Consultant
  Musculoskeletal Tumor Centre, Peking University People's Hospital
  Beijing, Beijing, China (People's Republic)
• XS

  Xin Sun, n/a

  Musculoskeletal Tumor Centre, Peking University People's Hospital
  Beijing, Beijing, China (People's Republic)
• TJ

  Tao Ji, n/a

  Musculoskeletal Tumor Centre, Peking University People's Hospital
  Beijing, Beijing, China (People's Republic)
• 

  Haiyan Hu, n/a

  Attending Physician
  Medical Oncology, Shanghai Sixth People's Hospital, Jiaotong University
  Shanghai, Shanghai, China (People's Republic)
• 

  Weitao Yao, n/a

  Director
  Boneand Soft Tissue Department, Henan Cancer Hospital/Affiliated Cancer Hospital of Zhengzhou University
  Zhengzhou, Henan, China (People's Republic)
• ZY

  Zhaoming Ye, n/a

  Orthopedics, The Second Affiliated Hospital Zhejiang University School of Medicine
  Hangzhou, Zhejiang, China (People's Republic)
• JZ

  Jianning Zhao, n/a

  Orthopedics, General Hospital of Eastern Theater Command
  Nanjing, Jiangsu, China (People's Republic)
• 

  Yingqi Hua, MD, PhD

  Professor
  Department of Orthopedic Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
  Shanghai, Shanghai, China (People's Republic)
• JW

  Jin Wang, n/a

  Bone and Soft Tissue Surgery,Sun Yat-Sen University Cancer Hospital
  Guangzhou, Guangdong, China (People's Republic)
• XL

  Xian an Li, n/a

  Orthopedics & Soft Tissue Department, Hunan Cancer Hospital
  Changsha, Hunan, China (People's Republic)
• MF

  Meiyu Fang, n/a

  Rare Cancer & Head and Neck Medical Oncology, Zhejiang Cancer Hospital - Cancer Research Institute
  Hangzhou, Zhejiang, China (People's Republic)
• GW

  Guowen Wang, n/a

  Bone Cancer Department, TMUCIH - Tianjin Medical University Cancer Institute and Hospital
  Tianjin, Tianjin, China (People's Republic)
• MZ

  Min Zhang, n/a

  Clinical Medical Centers, Shanghai Hansoh Bio Medical Co., Ltd
  Shanghai, Shanghai, China (People's Republic)
• BS

  Baili Song, n/a

  Clinical Medical Centers, Shanghai Hansoh Bio Medical Co., Ltd
  Shanghai, Shanghai, China (People's Republic)
• XH

  Xiaoyi Hu, n/a

  Clinical Medical Centers, Shanghai Hansoh Bio Medical Co., Ltd
  Shanghai, Shanghai, China (People's Republic)
• XZ

  Xiaoqing Zhang, n/a

  Clinical Medical Centers, Shanghai Hansoh Bio Medical Co., Ltd
  Shanghai, Shanghai, China (People's Republic)
• 

  Xiaodong Tang, n/a

  Chief
  Musculoskeletal Tumor Centre, Peking University People's Hospital
  Beijing, Beijing, China (People's Republic)
• WG

  Wei Guo, n/a

  Musculoskeletal Tumor Centre, Peking University People's Hospital
  Beijing, Beijing, China (People's Republic)